Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q2 2024 · 10-Q
Revenue$25.83M$25.83M+42.9% vs Q2 2023 Net Income$343.00K$343.00KN/M vs Q2 2023 EPS Diluted$0.01$0.01N/M vs Q2 2023 Gross Profit$4,550,000+340.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,442,000N/M Free Cash Flowderived$1,156,000— Margins · derivedGross margin17.6%+11.9 pt vs Q2 2023
Operating margin2.0%+18.4 pt vs Q2 2023
Net margin1.3%+19.6 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 8, 2024 · 39 d after period end